Cardiac xenotransplantation

Coronary Artery Disease

Volumn 15, Issue 2, 2004, Pages 99-105

  Pham, Michael X ^a,b,c   Hunt, Sharon A ^a   Johnson, Frances L ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute vascular rejection; Hyperacute rejection; Pig; Xenotransplantation; Zoonosis

Indexed keywords

15 DEOXYSPERGUALIN; AZATHIOPRINE; BREQUINAR; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

COMPLEMENT INHIBITION; GRAFT FAILURE; GRAFT REJECTION; HEART TRANSPLANTATION; HYPERACUTE GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; NONHUMAN; ORGAN DONOR; PRIMATE; PRIORITY JOURNAL; REVIEW; SWINE; XENOTRANSPLANTATION; ZOONOSIS;

ANIMALS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; SWINE; TRANSPLANTATION, HETEROLOGOUS; ZOONOSES;

EID: 1842557716     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200403000-00005     Document Type: Review

References (69)

1. Reemtsma K. Heterotransplantation. Transplant Proc 1969; 1:251-256.
2. Giles GR, Boehmig HJ, Amemiya H, Halgrimson CG, Starzl TE. Clinical heterotransplantation of the liver. Transplant Proc 1970; 2:506-512.
3. Hardy JD, Chavez CM. The first heart transplant in man: historical reexamination of the 1964 case in the light of current clinical experience. Transplant Proc 1969; 1:717-725.
4. Taniguchi S, Cooper DK. Clinical xenotransplantation: past, present and future. Ann R Coll Surg Engl 1997; 79:13-19.
5. Bailey LL, Nehlsen-Cannarelfa SL, Concepcion W, Jolley WB. Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 1985; 254:3321-3329. This is the most detailed clinical and laboratory report available on a primate to human cardiac xenograft and it provides a good descrption of what would now be described as acute vascular rejection.
6. Balner H, van Leeuwen A, van Vreeswijk W, Dersjant H, van Rood JJ. Leukocytes antigens of chimpanzees and their relation to human HL-A antigens. Transplant Proc 1970; 2:454-462.
7. Metzgar RS, Seigler HF. Tissue antigens of man and chimpanzees; their role in xenografting. Transplant Proc 1970; 2:463-467.
8. Barnes AD, Hawker RJ. Leukocyte antigens in baboons: a preliminary to tissue typing for organ grafting. Transplant Proc 1972; 4:37-42.
9. Nairne P, Allen I, Brazier M, Forrester D, Heap B, Kennedy I, et al. Animal-to-human transplants: the ethics of Xenotransplantation. London: Nuffield Council on Bioethics; 1996; 1-123.
10. Committee on xenograft transplantation, Institute of Medicine. Xenotransplantation: science, ethics, and public policy. Washington, DC: National Academy Press; 1996. This Institute of Medicine report contains an excellent section describing real and probable risks of disease transmission due to xenotransplantation. Rational recommendations are made regarding the need for risk assessment and disease surveillance in clinical trials.
11. Appel JZ 3rd, Buhler L, Cooper DK. The pig as a source of cardiac xenografts. J Card Surg 2001; 16:345-356.
12. Goddard MJ, Dunning J, Horsley J, Atkinson C, Pino-Chavez G, Wallwork J. Histopathology of cardiac xenograft rejection in the pig-to-baboon model. J Heart Lung Transplant 2002; 21:474-484.
13. Vial CM, Ostlie DJ, Bhatti FN, Cozzi E, Goddard M, Chavez GP, et al. Life supporting function for over one month of a transgenic porcine heart in a baboon. J Heart Lung Transplant 2000; 19:224-229.
14. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature 1907; 385:810-813.
15. Lai L, Kolber-Simonds D, Park KW, Cheong HT, Greenstein JL, Im GS, et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science. 2002; 295:1089-1092. This article reports the first successful disruption of the pig alpha 1,3-glycosyltransferase gene. Loss of gene function inhibits production of the cell surface carbohydrate primarily responsible for hyperacute rejection.
16. Ramsoondar JJ, Machaty Z, Costa C, Williams BL, Fodor WL, Bondioli KR. Production of alpha 1,-3 galactosyltransferase-knockout cloned pigs expressing human alpha 1,2-fucosulosyltranserase. Biol Reprod. 2003; 69:437-45.
17. Paradis K, Langford G, Long Z, Heneine W, Sandstrom P, Switzer WM, et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 1999; 285:1236-1241. A multinational group of scientists representing industry sponsors, a xenotransplantation working group, the CDC, and veterinary medicine screened 160 subjects with a history of pig tissue implantation or extracorporeal organ perfusion for evidene of PERV infection with validated molecular assays in four independent laboratories. No conclusive evidence of infection was found in any patient.
18. Rose AG, Cooper DK, Human PA, Reichanspurner H, Reichart B. Histopathology of hyperacute rejection of the heart: experimental and clinical observations in allografts and xenografts. J Heart Lung Transplant 1991; 10:223-234.
19. Platt JL, Fischel RJ, Matas AJ, Reit SA, Bolman RM, Bach FH. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 1901; 52:214-220. This well written article provides a detailed description of the immunohistological changes seen in hyperacute rejection.
20. Hammer C. Isohemagglutinins and preformed natural antibodies in xenogeneic organ transplantation. Transplant Proc 1987; 19:4443-4447.
21. Cooper DK, Good AH, Koren E, Oriol R, Malcolm AJ, Ippolito RM, et al. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl Immunol 1993; 1:198-205.
22. Galili U, Clark MR, Shohet SB, Buehler J, Macher BA. Evolutionary relationship between the natural anti-Gal antibody and Gal alpha 1-3Gal epitope in primates. Proc Natl Acad Sci USA 1987; 84:1369-1373.
23. Cooper DK, Koren E, Oriof R. Oligosaccharides and discordant xenotransplantation. Immunol Rev 1994; 141:31-58. The authors thoroughly review the role of αGal epitopes and anti-αGal antibodies in xenograft rejection and discuss strategies that later proved successful in attenuating this interaction.
24. Platt JL, Rachel RJ, Matas AJ, Reif SA, Bolman RM, Bach FH. Immunopathology of hyperacute xenograft rejection in a model. Transplantation 1991; 52:214-220.
25. Platt JL. The immunological hurdles to cardiac xenotransplantation. J Card Surg 2001; 16:439-447.
26. Brenner P, Hinz M, Huber H, Schmoeckel M, Reichenspurner H, Meiser B, et al. The influence of antibody and complement removal with a Ig-Therasorb column in a xenogeneic working heart model. Eur J Cerdiothorac Surg 1999; 15:672-679.
27. Leventhal JR, John R, Fryer JP, Witson JC, Derlich JM, Remiszewski J, et al. Removal of baboon and human antiporcine IgG and IgM natural antibodies by immunoadsorption. Results of in vitro and in vivo studies. Transplantation 1995; 59:294-300.
28. Simon PM, Neethling FA, Taniguchi S, Goode PL, Zopf D, Hancock WW, et al. Intravenous infusion of Galalpha1-3Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts. Transplantation 1998; 65:346-353.
29. Sandrin MS, Fodor WL, Mouhtouris E, Osman N, Cohney S, Rollins SA, et al. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1995; 1:1261-1267. This article reports the development of transgenic pigs which are partially resistant to rejection by expression of a human enzyme (H-transferase) that catalyzes the formation of the nonantigenic blood group O or H-antigen.
30. LaVecchio JA, Dunne AD, Edge AS. Enzymatic removal of alpha-galactosyl epitopes from porcine endothelial cells diminishes the cytotoxic effect of natural antibodies. Transplantation 1995; 60:841-847.
31. Osman N, McKenzie IF, Ostenried K, Ioannou YA, Desnick RJ, Sandrin MS. Combined transgenic expression of alpha-galactosidase and alpha1,2- fucosyltransferase leads to optimal reduction in the major xenoepitope Galalpha(1,3)Gal. Proc Natl Acad Sci USA 1997; 94:14677-14682.
32. Costa C, Zhao L, Burton WV, Bondioli KR, Williams BL, Hoagland TA, et al. Expression of the human alpha1,2-fucosyltransferase in transgenic pigs modifies the cell surface carbohydrate phenotype and confers resistance to human serum-mediated cytolysis. FASEB J 1999; 13:1762-1773.
33. Kobayashi T, Taniguchi S, Neethling FA, Rose AG, Hancock WW, Ye Y, et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation. 1997; 64:1255-1261.
34. Pruitt SK, Kirk AD, Bollinger RR, Marsh HC Jr, Collins BH, Levin JL, et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994; 57:363-370.
35. Pruitt SK, Bollinger RR, Collins BH, Marsh HC Jr, Levin JL, Rudolph AR, et al. Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts. Transplantation 1997; 63:900-902.
36. Fodor WL, Williams BL, Matis LA, Madri JA, Rollins SA, Knight JW, et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci USA 1994; 91:11153-11157. Excellent description of the rationale for and development of a transgenic pig expressing a human complement-inhibiting gene, CD59.
37. McCurry KR, Kooyman DL, Alvarado CG, Cotterell AH, Martin MJ, Logan JS, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995; 1:423-427.
38. Rosengard AM, Cary NR, Langford GA, Tucker AW, Wallwork J, White DJ. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. A potential approach for preventing xenograft rejection. Transplantation 1995; 59:1325-1333. Pioneering work in the area of transgenic biotechnology and complement inhibition in overcoming barriers to xenotransplantation.
39. Byrne GW, McCurry KR, Martin MJ, McClellan SM, Platt JL, Logan JS. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 1997; 63:149-155.
40. Schmoeckel M, Bhatti FN, Zaidi A, Cozzi E, Waterworth PD, Tolan MJ, et al. Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation 1998; 65:1570-1577.
41. Minanov OP, Artrip JH, Szabolcs M, Kwiatkowski PA, Galili U, Itescu S, et al. Triple immunosuppression reduces mononuclear cell infiltration and prolongs graft life in pig-to-newborn baboon cardiac xenotransplantation. J Thorac Cardiovasc Surg 1998; 115:998-1006.
42. Leventhal JR, Matas AJ, Sun LH, Reif S, Bolman RM 3rd, Dalmasso AP, et al. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation 1993; 56:1-8.
43. Hancock WW, Blakely ML, Van der Werf W, Bach FH. Rejection of guinea pig cardiac xenografts post-cobra venom factor therapy is associated with infiltration by mononuclear cells secreting interferon-gamma and diffuse endothelial activation. Transplant Proc 1993; 25:2932.
44. Goodman DJ, Von Albertini M, Willson A, Millan MT, Bach FH. Direct activation of porcine endothelial cells by human natural killer cells. Transplantation 1996; 61:763-771.
45. Lin SS, Weidner BC, Byrne GW, Diamond LE, Lawson JH, Hoopes CW, et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 1998; 101:1745-1756.
46. McCurry KR, Parker W, Cotterell AH, Weidner BC, Lin SS, Daniels LJ, et al. Humoral responses to pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation. Hum Immunol 1997; 58:91-105.
47. Bannett AD, McAlack RF, Morris M, Chopek MW, Platt JL. ABO incompatible renal transplantation: a qualitative analysis of native endothelial tissue ABO antigens after transplantation. Transplant Proc 1989; 21:783-785.
48. Parker W, Lin SS, Platt JL. Antigen expression in xenotransplantation: how low must it go? Transplantation 2001; 71:313-319.
49. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature (Lond) 1953; 172:603-606.
50. Streilein JW. Neonatal tolerance: towards an immunogenetic definition of self. Immunol Rev 1979; 46:123-146.
51. Sykes M, Lee LA, Sachs DH. Xenograft tolerance. Immunol Rev 1994; 141:245-276.
52. Ohdan H, Yang YG, Shimizu A, Swenson KG, Sykes M. Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection. J Clin Invest 1999; 104:281-290.
53. Ohdan H, Yang YG, Swenson KG, Kitamura H, Sykes M. T cell and B cell tolerance to GALalpha1,3GAL-expressing heart xenografts is achieved in alpha1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism. Transplantation 2001; 71:1532-1542.
54. Zhao Y, Swenson K, Sergio JJ, Arn JS, Sachs DH, Sykes M. Skin graft tolerance across a discordant xenogeneic barrier. Nat Med 1996; 2:1211-1216. This article is the first report of immune tolerance induction across a widely disparate species barrier; a mouse reconstituted with pig bone marrow and thymus showed no rejection of a pig skin graft.
55. Khan A, Sergio JJ, Zhao Y, Pearson DA, Sachs DH, Sykes M. Discordant xenogeneic neonatal thymic transplantation can induce donor-specific tolerance. Transplantation 1997; 63:124-131,
56. Sablinski T, Gianello PR, Bailin M, Bergen KS, Emery DW, Fishman JA, et al. Pig to monkey bone marrow and kidney xenotransplantation. Surgery 1997; 121:381-391.
57. Buhler L, Awwad M, Basker M, Gojo S, Watts A, Treter S, et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 2000; 69:2296-2304.
58. Shimizu A, Meehan SM, Kozlowski T, Sablinski T, Ierino FL, Cooper DK, et al. Acute humoral xenograft rejection: destruction of the microvascular capillary endothelium in pig-to-nonhuman primate renal grafts. Lab Invest 2000; 80:815-830.
59. Tanaka M, Murase N, Nomoto M, Demetris AJ, Todo S, Starzl TE. Tacrolimus (FK 506)-dependent tolerance after liver and heart xenotransplantation: inhibition of humoral response and acceptance of donor organs. Transplant Proc 1996; 28:679-680.
60. Fujino Y, Kawamura T, Hullett DA, Sollinger HW. Evaluation of cyclosporine, mycophenolate mofetil, and Brequinar sodium combination therapy on hamster-to-rat cardiac xenotransplantation. Transplantation 1994; 57:41-46.
61. Murase N, Starzl TE, Demetris AJ, Valdivia L, Tanabe M, Cramer D, et al. Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation 1993; 55:701-707, discussion 707-708.
62. Krook H, Wennberg L, Hagberg A, Song Z, Groth CG, Korsgren O. Immunosuppressive drugs in islet xenotransplantation: a tool for gaining further insights in the mechanisms of the rejection process. Transplantation 2002; 74:1084-1089.
63. Lee RS, Yamada K, Womer KL, Pillsbury EP, Allison KS, Marolewski AE, et al. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses. J Immunol 2000; 164:3434-3444.
64. Onions D, Cooper DK, Alexander TJ, Brown C, Claassen E, Foweraker JE, et al. An approach to the control of disease transmission in pig-to-human xenotransplantation. Xenotransplantation 2000; 7:143-155.
65. Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997; 3:282-286. This article was the first to show the ability of pig endogenous retroviruses to infect human cells in vitro.
66. Martin U, Kiessig V, Blusch JH, Haverich A, von der Helm K, Herden T, et al. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet 1998; 352:692-694.
67. Patience C, Patton GS, Takeuchi Y, Weiss RA, McClure MO, Rydberg L, et al. No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet 1998; 352:699-701.
68. Heneine W, Tibell A, Switzer WM, Sandstrom P, Rosales GV, Mathews A, et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 1998; 352:695-699.
69. Cooper DK, Keogb AM, Brink J, Corris PA, Klepetko W, Pierson RN, et al. Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases. J Heart Lung Transplant 2000; 19:1125-1165. An international working group of transplantation professionals provides specific recommendations on prerequisites for clinical trails in cardiac zenotransplantation.